You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-PDGF Receptor beta (phospho Y1021) antibody (ab62437)

Overview

  • Product nameAnti-PDGF Receptor beta (phospho Y1021) antibodySee all PDGF Receptor beta primary antibodies ...
  • Description
    Rabbit polyclonal to PDGF Receptor beta (phospho Y1021)
  • SpecificityThis antibody detects endogenous levels of PDGF Receptor beta only when phosphorylated at tyrosine 1021.
  • Tested applicationsIHC-P, ELISA, WB more details
  • Species reactivity
    Reacts with: Mouse, Human
  • Immunogen

    Synthetic phosphopeptide derived from human PDGF Receptor beta around the phosphorylation site of tyrosine 1021 (N-D-YP-I-I).

  • Positive controlHuman brain tissue.

Properties

Applications

Our Abpromise guarantee covers the use of ab62437 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC-P IHC-P: 1/50 - 1/100.
ELISA ELISA: 1/5000.
WB WB: Use at an assay dependent dilution.

Target

  • FunctionReceptor that binds specifically to PDGFB and PDGFD and has a tyrosine-protein kinase activity. Phosphorylates Tyr residues at the C-terminus of PTPN11 creating a binding site for the SH2 domain of GRB2.
  • Involvement in diseaseNote=A chromosomal aberration involving PDGFRB is found in a form of chronic myelomonocytic leukemia (CMML). Translocation t(5;12)(q33;p13) with EVT6/TEL. It is characterized by abnormal clonal myeloid proliferation and by progression to acute myelogenous leukemia (AML).
    Note=A chromosomal aberration involving PDGFRB may be a cause of acute myelogenous leukemia. Translocation t(5;14)(q33;q32) with TRIP11. The fusion protein may be involved in clonal evolution of leukemia and eosinophilia.
    Note=A chromosomal aberration involving PDGFRB may be a cause of juvenile myelomonocytic leukemia. Translocation t(5;17)(q33;p11.2) with SPECC1.
    Defects in PDGFRB are a cause of myeloproliferative disorder chronic with eosinophilia (MPE) [MIM:131440]. A hematologic disorder characterized by malignant eosinophils proliferation. Note=A chromosomal aberration involving PDGFRB is found in many instances of myeloproliferative disorder chronic with eosinophilia. Translocation t(5;12) with ETV6 on chromosome 12 creating an PDGFRB-ETV6 fusion protein.
    Note=A chromosomal aberration involving PDGFRB may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP-PDGFRB fusion protein.
  • Sequence similaritiesBelongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
    Contains 5 Ig-like C2-type (immunoglobulin-like) domains.
    Contains 1 protein kinase domain.
  • Post-translational
    modifications
    Autophosphorylated. Dephosphorylated by PTPRJ at Tyr-751, Tyr-857, Tyr-1009 and Tyr-1021.
  • Cellular localizationMembrane.
  • Target information above from: UniProt accession P09619 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Beta platelet derived growth factor receptor antibodyBeta-type platelet-derived growth factor receptor antibodyCD 140B antibody
      CD140 antigen-like family member B antibodyCD140B antibodyCD140b antibodyCD140b antigen antibodyIBGC4 antibodyJTK12 antibodyOTTHUMP00000160528 antibodyPDGF R beta antibodyPDGF-R-beta antibodyPDGFR 1 antibodyPDGFR antibodyPDGFR beta antibodyPDGFR1 antibodyPDGFRB antibodyPGFRB_HUMAN antibodyPlatelet derived growth factor receptor 1 antibodyPlatelet derived growth factor receptor beta antibodyPlatelet derived growth factor receptor beta polypeptide antibody
    see all

Anti-PDGF Receptor beta (phospho Y1021) antibody images

  • Immunohistochemical analysis of paraffin embedded human brain tissue using ab62437 at 1/50 dilution, in the presence (right) and absence (left) of immunising phosphopeptide.


  • Performed under reducing conditions.

    Observed band size : 125 kDa (why is the actual band size different from the predicted?)
    Additional bands at : 60 kDa. We are unsure as to the identity of these extra bands.

    Exposure time : 15 seconds

    This image is courtesy of an Abreview submitted by Lars Ruether

    See Abreview

  • ab62437 staining the PDGF Receptor beta (phospho Y1021) in epithelial cells in Mouse brain tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and blocked with 0.5% BSA for 20 minutes at room temperature; antigen retrieval was by heat mediation with citric acid (pH6.0). Samples were incubated with primary antibody (1/50 in 0.5% BSA/PBS) for 1 hour. An undiluted HRP-conjugated Goat anti-rabbit polyclonal was used as the secondary antibody.

    See Abreview

References for Anti-PDGF Receptor beta (phospho Y1021) antibody (ab62437)

ab62437 has not yet been referenced specifically in any publications.

Product Wall

Displaying 1 - 5 of 5 results for Abreviews and Q&A

Application Immunohistochemistry (PFA perfusion fixed frozen sections)
Sample Mouse Tissue (Brian section)
Specification Brian section
Fixative Paraformaldehyde
Permeabilization Yes - 0.1% TritonX in 0.1% PBS
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: 24°C
Username

Verified customer

Submitted Feb 18 2013

Thank you for your message.

I would like to reassure you that although these antibodies are recommended to be stored at -20oC, I would not expect being at 4oC for a few days to significantly affect their performance. However, I would recommend ...

Read More
Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Human Tissue sections (human non-neoplastic cortex)
Specification human non-neoplastic cortex
Fixative Paraformaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: citrit acid pH 6.1
Permeabilization No
Blocking step BSA as blocking agent for 20 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Verified customer

Submitted Dec 03 2010

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Mouse Tissue sections (epithelia cells in mouse brain tissue)
Specification epithelia cells in mouse brain tissue
Fixative Paraformaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: citric acid pH 6.0
Permeabilization No
Blocking step BSA as blocking agent for 20 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Verified customer

Submitted Nov 16 2010

Application Western blot
Sample Human Cell lysate - whole cell (Brain (Glioblastoma))
Loading amount 100 µg
Specification Brain (Glioblastoma)
Treatment PDGF-BB: 20 & 40 ng/ml for 5, 10, 15 min.
Gel Running Conditions Reduced Denaturing
Blocking step BSA as blocking agent for 1 hour(s) and 30 minute(s) · Concentration: 5% · Temperature: RT°C
Username

Verified customer

Submitted Sep 27 2010

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"